| [By Lynn Eaton, BMJ.]
http://bmj.com/cgi/content/full/324/7333/315/a?view=full&pmid=11834548
Controversial new research showing that many children
with both autism and bowel disease have the measles
virus in their intestinal tissue has fuelled further
debate over the possible link between the illness
and the measles, mumps, and rubella vaccine <<...
although no such link is proved in the research.
The paper, to be published shortly by the specialist
journalMolecular
Pathology (which is co-owned by the BMJ Publishing
Group) and already
available on its website (<http://mp.bmjjournals.com/cgi/content/full/54/6/DC1),
was highlighted by a television programme (Panorama,
BBC1, 3 Feb) on the safety of the MMR vaccine.
It looked at tissue samples of 91 children from
the Royal Free Hospital, London, who had both
autism and inflammatory bowel disease. Seventy
five of the samples tested positive for the presence
of measles virus in intestinal tissue, compared
with five of 70 controls.
Professor John O'Leary, of the department of
pathology at Coombe Women's Hospital, Dublin,
who undertook the analysis, emphasised that the
results did not prove that any of the children
acquired their condition as a result of being
vaccinated.
"You can't say at the moment that it is
linked to the vaccine," he said. "There
are several strains of the virus out there. They
could have picked it up from the wild virus."
But he thought it unlikely that parents would
have missed measles symptoms in their child. "A
measles rash is pretty classic," he said.
"The child is irritable and gets a fever.
The parents would probably have spotted that."
He said the paper had been very carefully prepared,
because this was such a major public health issue.
"It is fair to say these children are not
representative of autism per se," he said.
"It is a very distinctive subset. The important
point we are trying to get across is that it is
a biological association."
Alan Morris, reader in the department of biological
sciences, Warwick University, and author of the
journal's commentary on the paper, described it
as "interesting." "The paper is
technically good. The data look fine, but it is
looking at an unusual subset of children and it
proves nothing. Its implications will only come
out in the wash." But one of the paper's
authors, Dr Andrew Wakefield, a former senior
lecturer at the Royal Free Hospital and the main
advocate for a link between the MMR vaccine and
autism (Lancet 1998;351:637-41[Medline] </cgi/external_ref?access_num=9500320&link_type=MED),
said the study raised important questions.
"We don't know whether it is the vaccine
strain or not," he admitted, "but these
children's only exposure has been to the vaccine
strain. None of them had a history of measles.
It takes the science to an entirely new level."
Dr Wakefield worked at the Royal Free Hospital,
where the samples came from, until last November,
when he was told that his research was "no
longer in line with the department of medicine's
research strategy."
* * *
What it DOES Prove
http://bmj.com/cgi/eletters/324/7333/315/a#19463
The response I have read proves one thing. The
status quo is being defended "at all odds"
while kids continue to be adversely affected by
something which no-one is prepared to look into
seriously. Most of the responses to Wakefield's
work and his potentially alarming findings has
been a rather shameful reactive and data-fudging
repetitive reassertion of "It is all OK "
when it clearly is not.
While it is equally clear that the majority do
not get adversely affected, until we know what
it is about the subgroup who do report time-associated
reactions, it surely behoves the companies who
make these vaccines or the governments who advocate
them in such a fear-engendering way, to respond
with research designed to find out why. Otherwise
the charge that all is directed to protecting
drug company profit will hang around.
My reading suggests that those with a family
history of G-protein related diseases are more
likely to react. Many of the patients I have,
who complain of fundamental changes in their childrens
character or of the onset of a condition classifiable
as part of the autistic spectrum also report night
blindess in one of the parents. This issue has
already been addressed by Dr Mary Megson, but
the association and its implications remains unaddressed
by the research community unless I am mistaken.
The statisticians and vaccine advocates always
seem to forget that STATISTICS RELATING TO VACCINE
SAFETY MEAN ABSOLUTLEY NOTHING when your child
is affected FOR LIFE. Until such independant rigourous
and exhaustive research has been conducted into
this issue along with other vaccine associated
concerns I remain supportive of parents rights
to decide whether or not to vaccinate their children.
Philip Stowell, Brisbane, Australia.
GP and father of two boys
www.feat.org
|